ScholarIQanswers from OpenAlex

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update

PaperCitations, authors & open-access status

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update have?

ScholarIQcitation count

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has 11 citations in the OpenAlex counts ScholarIQ stores.

When was Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update published?

ScholarIQyear

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has 2025 year in the ScholarIQ index.

What is the open-access status of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?

ScholarIQoa status

Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update has gold oa status in the ScholarIQ index.

What is the DOI of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?

ScholarIQdoi

The DOI for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.

What is the PMID of Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?

ScholarIQpmid

The PMID for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.

What is the OpenAlex record for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update?

ScholarIQopenalex

The OpenAlex for Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial